Technology Commercialization Office

Showing 13 result(s) for "Drug Delivery"



A treatment for spinal muscular atrophy.

A novel method to improve CNS metabolism and overall cognitive function as well as reduce peripheral neurodeneration, through the use of nanomatrices with or without identified redefined delivery biologicals and/or insulin.

Three-way junction nanoparticles for delivery of tamoxifen and other therapeutics directly to tumor cells.

Novel strategy to improve efficiency and specificity of tumor treatment via combinative use of a split & splice protein toxin and oncolytic virus.

Biodegradable polymeric implants for local delivery of therapeutic agents to cancer sites as an alternative to traditional radiation or chemotherapy treatments.

Novel lipid-based nanoparticles that utilize a surfactant to improve self-assembly and stability. Finalized particles can be used for delivery of nucleic acids such as oligonucleotides and plasmid DNA.

An efficient delivery vehicle for therapeutic oligonucleotides with high efficiency.

Self-assembling, highly stable RNA cages amenable to custom functionalization and cargo delivery

Innovative thermogenic biologicals, methods of delivery, and combinational therapy for the treatment of abdominal obesity

An improved delivery mechanism has been developed for hydrophobic drugs such as camptothecin which will increase chemotherapeutic efficacy.